Platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) BriefCommunication Pages: 887 - 887
Cyclooxygenase-2 (COX-2); prostaglandin E2 (PGE2); VEGF receptor 2 (KDR/Flk-1; VEGFR-2) BriefCommunication Pages: 888 - 888
Epidermal growth factor receptor 3 (EGFR3; HER3; ErbB3); HER2 (EGFR2; ErbB2; neu); EGFR BriefCommunication Pages: 889 - 889
Circulating tumor cell (CTC) drug susceptibility screening to predict patient response BriefCommunication Pages: 903 - 903
In vitro screen for small molecules to promote myelin repair in multiple sclerosis (MS) BriefCommunication Pages: 904 - 904
Preeclampsia diagnostic based on amyloid oligomer content of urine BriefCommunication Pages: 905 - 905
Mouse models of myeloid cancers created with clustered, regularly interspaced short palindromic repeats (CRISPR)-mediated genome editing BriefCommunication Pages: 907 - 907
Therapeutic suitability of induced pluripotent stem (iPS) cells versus nuclear transfer embryonic stem cells (NT-ESCs) BriefCommunication Pages: 908 - 908
Microfluidic system that uniformly encapsulates islets of Langerhans to treat type 1 diabetes BriefCommunication Pages: 910 - 910
Intraoperative identification of isocitrate dehydrogenase 1 ( IDH1 )-mutant brain tumors via rapid mass spectrometric detection of 2-hydroxyglutarate (2-HG) BriefCommunication Pages: 911 - 911
Lentivirus with baboon retroviral envelope glycoprotein for enhanced hematopoietic stem cell (HSC) therapy BriefCommunication Pages: 912 - 912